Boston Trust Walden
MEDP icon

Boston Trust Walden’s Medpace MEDP Stock Holding History

Boston Trust Walden’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$90.4M Sell
144,843
-10,674
-7% -$6.25M 0.73% 31
2026
Q2 		$82.4M Buy
155,517
+14,907
+11% +$6.88M 0.63% 48
2026
Q1 		$67.5M Sell
140,610
-7,391
-5% -$3.78M 0.56% 58
2025
Q4 		$83.1M Sell
148,001
-3,199
-2% -$1.82M 0.63% 45
2025
Q3 		$77.7M Buy
151,200
+126
+0.1% +$55K 0.57% 53
2025
Q2 		$47.4M Buy
151,074
+16,270
+12% +$4.88M 0.34% 122
2025
Q1 		$41.1M Buy
134,804
+229
+0.2% +$77K 0.3% 131
2024
Q4 		$44.7M Buy
134,575
+4,920
+4% +$1.67M 0.31% 130
2024
Q3 		$43.3M Sell
129,655
-28,296
-18% -$10.7M 0.3% 134
2024
Q2 		$65.1M Sell
157,951
-109,064
-41% -$43.2M 0.48% 71
2024
Q1 		$108M Sell
267,015
-221,256
-45% -$77.8M 0.77% 32
2023
Q4 		$150M Sell
488,271
-51,684
-10% -$14M 1.13% 15
2023
Q3 		$131M Sell
539,955
-9,952
-2% -$2.55M 1.1% 15
2023
Q2 		$132M Sell
549,907
-12,728
-2% -$2.64M 1.08% 15
2023
Q1 		$106M Buy
562,635
+15,193
+3% +$3.14M 0.91% 23
2022
Q4 		$116M Sell
547,442
-151,618
-22% -$30.3M 1.02% 16
2022
Q3 		$110M Buy
699,060
+10,282
+1% +$1.64M 1.09% 14
2022
Q2 		$103M Buy
688,778
+13,784
+2% +$2M 0.97% 18
2022
Q1 		$110M Buy
674,994
+186,518
+38% +$30.8M 0.91% 21
2021
Q4 		$106M Sell
488,476
-39,915
-8% -$8.36M 0.85% 25
2021
Q3 		$100M Buy
528,391
+2,164
+0.4% +$395K 0.89% 22
2021
Q2 		$92.9M Sell
526,227
-16,891
-3% -$2.92M 0.83% 24
2021
Q1 		$89.1M Buy
543,118
+33,488
+7% +$5.12M 0.86% 23
2020
Q4 		$70.9M Buy
509,630
+101,346
+25% +$12.8M 0.76% 29
2020
Q3 		$45.6M Buy
408,284
+14,749
+4% +$1.71M 0.57% 50
2020
Q2 		$36.6M Buy
+393,535
New +$33.5M 0.49% 62

Other funds holding MEDP

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Boston Trust Walden's MEDP Position: Q3 2026 in Review

Boston Trust Walden reduced its Medpace (MEDP) stake by 6.9% in Q3 2026, selling an estimated $6.25M and leaving 144,843 shares worth $90.4M. The position accounts for 0.73% of the portfolio, ranked #31.

Boston Trust Walden first reported a position in MEDP in Q2 2020 and has held it in 26 quarters since. The position peaked at $150M in Q4 2023. 619 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Boston Trust Walden held 144,843 shares of Medpace worth $90.4M as of Q3 2026.
  • Boston Trust Walden sold 10,674 Medpace shares in Q3 2026, an estimated $6.25M.
  • Medpace made up 0.73% of Boston Trust Walden's portfolio in Q3 2026, its #31 holding.
  • Boston Trust Walden first reported a position in Medpace in Q2 2020 and has held it in 26 quarters since.
  • Boston Trust Walden's Medpace position peaked at $150M in Q4 2023.
  • 619 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.